Xu Yan Selected Research

Rhizomucor pusillus infection

3/2022

Aggressive disseminated Rhizomucor pusillus infection in a Ph-like acute lymphoblastic leukemia patient: Early detection by cell-free DNA next-generation sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Yan Research Topics

Disease

46	Neoplasms (Cancer) 01/2022 - 01/2010
14	Hypoxia (Hypoxemia) 01/2022 - 01/2014
11	Infections 03/2022 - 01/2015
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2008
9	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
9	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2015
9	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2013
9	Glioma (Gliomas) 01/2022 - 01/2018
8	Parkinson Disease (Parkinson's Disease) 09/2022 - 02/2015
8	Inflammation (Inflammations) 08/2022 - 01/2010
8	Fibrosis (Cirrhosis) 04/2021 - 07/2011
8	Wounds and Injuries (Trauma) 01/2021 - 01/2015
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2009
7	Maternal Obesity 07/2014 - 04/2009
6	Stroke (Strokes) 05/2022 - 01/2012
5	Insulin Resistance 01/2022 - 02/2008
5	Obesity 01/2022 - 04/2009
5	Ischemia 01/2017 - 01/2014
4	Ischemic Stroke 04/2022 - 01/2016
4	Leukemia 03/2022 - 09/2015
4	Heart Failure 01/2022 - 07/2015
4	Body Weight (Weight, Body) 01/2022 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2017
3	Demyelinating Diseases (Demyelinating Disease) 03/2022 - 01/2018
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2019
3	Neuroinflammatory Diseases 01/2022 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2016
3	Hyperthermia 01/2022 - 04/2020
3	Necrosis 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2010
3	Brain Edema (Cerebral Edema) 03/2021 - 01/2016
3	Synucleinopathies 01/2021 - 02/2015
3	Osteoporosis 01/2021 - 09/2020
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2010
3	Tauopathies 01/2020 - 01/2016
2	Non-alcoholic Fatty Liver Disease 08/2022 - 01/2019
2	Cognitive Dysfunction 04/2022 - 01/2022
2	Spinal Cord Diseases 01/2022 - 10/2016
2	Ventricular Remodeling 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2021
2	Liver Diseases (Liver Disease) 04/2021 - 12/2017
2	Esophageal Squamous Cell Carcinoma 03/2021 - 06/2016
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 11/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2019
2	Reperfusion Injury 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 09/2022 - 11/2008
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
10	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
9	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
6	Small Interfering RNA (siRNA)IBA 03/2022 - 12/2012
6	Biological ProductsIBA 01/2021 - 12/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2008
5	Circular RNAIBA 01/2022 - 01/2018
5	CytokinesIBA 04/2021 - 07/2011
5	Insulin (Novolin)FDA Link 07/2014 - 02/2008
4	Peptide Hydrolases (Proteases)FDA Link 08/2021 - 09/2011
4	GadoliniumIBA 03/2020 - 11/2017
4	Immunoglobulin G (IgG)IBA 01/2020 - 01/2015
3	LipidsIBA 08/2022 - 07/2011
3	InflammasomesIBA 08/2022 - 01/2020
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
3	HydrogelsIBA 01/2022 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2010
3	EnzymesIBA 12/2021 - 12/2018
3	RNA (Ribonucleic Acid)IBA 09/2021 - 01/2019
3	VaccinesIBA 07/2021 - 01/2015
3	Peptides (Polypeptides)IBA 04/2021 - 03/2017
3	SynucleinsIBA 01/2021 - 02/2015
3	NF-kappa B (NF-kB)IBA 01/2021 - 04/2009
3	Therapeutic UsesIBA 12/2020 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 12/2016
2	Dynamins (Dynamin)IBA 09/2022 - 09/2021
2	Cystatin CIBA 04/2022 - 01/2022
2	SilverIBA 03/2022 - 01/2022
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2011
2	PrebioticsIBA 01/2022 - 01/2021
2	Aquaporins (Water Channels)IBA 01/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 07/2011
2	LipopolysaccharidesIBA 11/2021 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2014
2	clonidine-displacing substance (ClDS)IBA 04/2021 - 12/2017
2	IronIBA 04/2021 - 10/2018
2	Methylene Blue (Methylthioninium Chloride)FDA Link 03/2021 - 01/2016
2	Aquaporin 4IBA 03/2021 - 01/2017
2	Cathepsin BIBA 01/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	Prolyl OligopeptidasesIBA 08/2020 - 02/2015
2	Contrast MediaIBA 07/2020 - 03/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 07/2020 - 05/2020
2	3,4,5,3',4'-pentachlorobiphenylIBA 05/2020 - 01/2019

Therapy/Procedure

16	Therapeutics 01/2022 - 12/2012
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
5	Neoadjuvant Therapy 01/2022 - 09/2017
2	Immunotherapy 01/2022 - 07/2021
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 10/2018
2	Laminoplasty 01/2022 - 10/2016
2	Fecal Microbiota Transplantation 01/2022 - 01/2021
2	Aftercare (After-Treatment) 01/2022 - 12/2016
2	Liver Transplantation 11/2020 - 06/2013